Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Feb;63(2):278-80.
doi: 10.1001/archneur.63.2.278.

Phenotypic variability among adult siblings with Sjögren-Larsson syndrome

Alexander Lossos  1 , Moona Khoury, William B Rizzo, John M Gomori, Eyal Banin, Abraham Zlotogorski, Saleh Jaber, Oded Abramsky, Zohar Argov, Hanna Rosenmann
Affiliations
Case Reports

Phenotypic variability among adult siblings with Sjögren-Larsson syndrome

Alexander Lossos et al. Arch Neurol. 2006 Feb.

Abstract

Background: Sjögren-Larsson syndrome (SLS) is an early childhood-onset disorder with ichthyosis, mental retardation, spastic paraparesis, macular dystrophy, and leukoencephalopathy caused by the deficiency of fatty aldehyde dehydrogenase due to mutations in the ALDH3A2 gene (the gene that encodes microsomal fatty aldehyde dehydrogenase). Cerebral proton magnetic resonance spectroscopy in those with SLS demonstrates an abnormal white matter peak at 1.3 ppm, consistent with long-chain fatty alcohol accumulation.

Objective: To define the clinical course and proton magnetic resonance spectroscopic findings of SLS in adults.

Design and setting: Case series in a tertiary care center.

Patients: Six siblings of a consanguineous Arab family with early childhood-onset SLS who carry the 682C-->T mutation in the ALDH3A2 gene were reinvestigated in adulthood.

Results: The 6 affected siblings ranged in age from 16 to 36 years. All exhibited the typical clinical and imaging manifestations of SLS, but their severity markedly varied. Neurological involvement was apparently nonprogressive, and its severity showed no correlation with age. Cerebral proton magnetic resonance spectroscopy showed a lipid peak at 1.3 ppm, with decreasing intensity in the older siblings.

Conclusion: These observations document significant clinical variability and the nonprogressive neurological course of SLS in adult siblings with the same ALDH3A2 genotype, and demonstrate possible correlation of proton magnetic resonance spectroscopic changes with age, suggesting unknown pathogenic mechanisms to compensate for the responsible biochemical defect in this disease.

PubMed Disclaimer

References

    1. Rizzo WB. Sjögren-Larsson syndrome: fatty aldehyde dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8. New York, NY: McGraw-Hill Co; 2001. pp. 2239–2258.
    1. Willemsen MA, Ijlst L, Steijlen PM, et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain. 2001;124(pt 7):1426–1437. - PubMed
    1. Willemsen MA, van der Graaf M, van der Knaap MS, et al. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol. 2004;25:649–657. - PMC - PubMed
    1. Rizzo WB. Sjögren-Larsson syndrome. Neurology. 1999;52:1307–1308. - PubMed
    1. Gomori JM, Leibovici V, Zlotogorski A, Wirguin I, Haham-Zadeh S. Computed tomography in Sjögren-Larsson syndrome. Neuroradiology. 1987;29:557–559. - PubMed

Publication types

Substances